Mounjaro 2.5mg Injection – Tirzepatide 2.5mg

Mounjaro 2.5mg Injection contains tirzepatide, a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It is administered once weekly by subcutaneous injection.

Tirzepatide works through two complementary incretin pathways. It enhances glucose-dependent insulin secretion, reduces glucagon secretion, slows gastric emptying, and influences appetite and food intake. These effects can help improve blood glucose control and may result in weight reduction.

2.5mg is the recommended starting dose and is generally used during treatment initiation to help the body adjust to tirzepatide. It is not intended as a maintenance dose. Dose increases should be made according to the prescribing healthcare professional’s instructions.

Prescription Required.

Product Information

How It Works

Tirzepatide activates both GIP and GLP-1 receptors. This helps improve glucose-dependent insulin secretion, reduce glucagon levels, slow gastric emptying, and regulate appetite and food intake.

Administration

Mounjaro is administered once weekly by subcutaneous injection into the abdomen, thigh, or upper arm. It can generally be administered with or without food.

Injection sites should be rotated. Follow the prescribed dose-escalation schedule and the instructions supplied with the specific Mounjaro device.

Common Side Effects

• Nausea
• Diarrhea
• Decreased appetite
• Vomiting
• Constipation
• Abdominal discomfort
• Indigestion

Important Safety Information

Important risks include pancreatitis, gallbladder disease, dehydration and kidney problems, hypoglycemia when used with insulin or insulin secretagogues, and serious hypersensitivity reactions.

Mounjaro carries a boxed warning concerning thyroid C-cell tumors and should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Tell your healthcare professional about other medicines you take, particularly insulin or sulfonylureas, because dose adjustments may be necessary.

Storage

Store according to the manufacturer’s instructions. Keep refrigerated and protect from light. Do not freeze. Follow the product packaging/prescribing information for the specific storage requirements.